P2Y12 INHIBITOR
Clinical trials for P2Y12 INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new P2Y12 INHIBITOR trials appear
Sign up with your email to follow new studies for P2Y12 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study tests whether using just one blood thinner (single antiplatelet therapy) is safer and as effective as two blood thinners (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a heart procedure with a drug-coated balloon. About 576 p…
Matched conditions: P2Y12 INHIBITOR
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated May 26, 2026 07:11 UTC
-
One drug at a time: new study aims to cut bleeding risk in heart patients
Disease control Recruiting nowThis study tests a new approach for people with atrial fibrillation who have received a heart stent. Instead of taking multiple blood thinners together for months, the plan uses just one drug at a time: an antiplatelet for the first month, then a different blood thinner long-term…
Matched conditions: P2Y12 INHIBITOR
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated May 26, 2026 07:02 UTC